Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shunsuke Kondo

Showing results (1-10 of 199) with videos related to

Pageof 20
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 1, 2018
[Molecular-targeted Therapies in Gastrointestinal Cancer]Shunsuke Kondo
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|March 13, 2025
Comments on "Effect of platelet storage duration on platelet increment and clinical outcomes in critically ill patients - A randomised controlled trial"Shunsuke Kondo
World Journal of Gastroenterology|September 28, 2016
Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinomaShiro Kimbara, Shunsuke Kondo
Expert Opinion on Pharmacotherapy|June 19, 2018
Oral chemotherapy for the treatment of hepatocellular carcinomaShun Yamamoto, Shunsuke Kondo
Future Oncology (London, England)|March 18, 2016
Trends in the development of MET inhibitors for hepatocellular carcinomaHitomi S Okuma, Shunsuke Kondo
Expert Opinion on Pharmacotherapy|June 26, 2023
Recent updates in the use of pharmacological therapies for downstaging in patients with hepatocellular carcinomaTakeshi Takamoto, Yuta Maruki, Shunsuke Kondo
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 26, 2025
Comments on "Effect of colistin combined with sulbactam: 9 g versus 12 g per day on mortality in the treatment of carbapenems resistant Acinetobacter baumannii pneumonia: a randomized controlled trial"Shunsuke Kondo, Takafumi Kubota, Yasushi Tsujimoto
Journal of Palliative Medicine|March 2, 2013
Glycemia control using A1C level in terminal cancer patients with preexisting type 2 diabetesShunsuke Kondo, Makoto Kondo, Akira Kondo
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 22, 2010
[Hepatocellular carcinoma]Shunsuke Kondo, Hideki Ueno, Chigusa Morizane, et al.
Biomed Research International|July 11, 2015
Clinical Development of Immune Checkpoint InhibitorsAyumu Ito, Shunsuke Kondo, Kohei Tada, et al.
Pageof 20

Showing results (1-10 of 199) with videos related to

Sort By:
Pageof 20
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 1, 2018
[Molecular-targeted Therapies in Gastrointestinal Cancer]Shunsuke Kondo
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|March 13, 2025
Comments on "Effect of platelet storage duration on platelet increment and clinical outcomes in critically ill patients - A randomised controlled trial"Shunsuke Kondo
World Journal of Gastroenterology|September 28, 2016
Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinomaShiro Kimbara, Shunsuke Kondo
Expert Opinion on Pharmacotherapy|June 19, 2018
Oral chemotherapy for the treatment of hepatocellular carcinomaShun Yamamoto, Shunsuke Kondo
Future Oncology (London, England)|March 18, 2016
Trends in the development of MET inhibitors for hepatocellular carcinomaHitomi S Okuma, Shunsuke Kondo
Expert Opinion on Pharmacotherapy|June 26, 2023
Recent updates in the use of pharmacological therapies for downstaging in patients with hepatocellular carcinomaTakeshi Takamoto, Yuta Maruki, Shunsuke Kondo
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 26, 2025
Comments on "Effect of colistin combined with sulbactam: 9 g versus 12 g per day on mortality in the treatment of carbapenems resistant Acinetobacter baumannii pneumonia: a randomized controlled trial"Shunsuke Kondo, Takafumi Kubota, Yasushi Tsujimoto
Journal of Palliative Medicine|March 2, 2013
Glycemia control using A1C level in terminal cancer patients with preexisting type 2 diabetesShunsuke Kondo, Makoto Kondo, Akira Kondo
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 22, 2010
[Hepatocellular carcinoma]Shunsuke Kondo, Hideki Ueno, Chigusa Morizane, et al.
Biomed Research International|July 11, 2015
Clinical Development of Immune Checkpoint InhibitorsAyumu Ito, Shunsuke Kondo, Kohei Tada, et al.
Pageof 20